Diagnos Inc DGNOF

$0.27 -0.01 (-3.64%)

Valuation

Market cap
33,613,000
Revenue TTM
$50,000
Net income TTM
$-3,300,000
PE ratio
0.00
Forward PE
—
Profit margin
-6,600.00%
Debt to equity
1.76

Trading

Volume
4,500
Avg volume
110,846
Day's range
$0.27 – $0.28
Shares out
124,493,000
Stochastic %K
0%
Beta
-0.02
Analysts
Strong Buy
Price target
—

Price

Company profile

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The compan...

Show more

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Industry
Health Information Services
Sector
Healthcare
Phone
450 678 8882
Website
https://diagnosmedical.com
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Canada

Latest news

No headlines yet.